Uwe M.
- Country
- Germany
- Department
- Klinik für Innere Medizin III:Hämatologie, Onkologie und Pall
Research Overview
- Phase I Evaluation of FS222 for Safety and Efficacy in Patients with Advanced Malignancies
- A Randomized, Open-label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-miniCHOP) in Older Adults with Untreated Diffuse Large B-Cell Lymphoma (ARCHED/GLA 2022-1)
- Evaluation of Safety and Efficacy of Targeted Therapies in Metastatic Colorectal Cancer Subpopulations
Data & Insights
Has run more than one trial at 291 of 568 partner sites.
Specializations
Gastrointestinal Oncology
Specializes in the treatment of gastric and gastroesophageal junction cancers, with particular focus on advanced and metastatic disease. Conducts research in HER2-positive and HER2-negative gastric adenocarcinomas, exploring novel therapeutic combinations.
- Gastric Cancer
- Colorectal Cancer
- Pancreatic Ductal Adenocarcinoma
Hematologic Malignancies
Investigates innovative treatments for blood cancers, with expertise in multiple myeloma and chronic lymphocytic leukemia. Studies include evaluation of novel therapeutic combinations and maintenance strategies post-transplantation.
- Multiple Myeloma
- Diffuse Large B-Cell Lymphoma
- Chronic Lymphocytic Leukemia
Precision Medicine
Leads research in biomarker-driven therapies and tumor-agnostic approaches. Focuses on targeted treatments across multiple solid tumor types, including studies of novel immunotherapy combinations.
- Pan-Tumor Studies
- Advanced Melanoma
- Molecular-Targeted Therapies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.